Current Issue March 2012, Vol. 24, No. 2

Issue Highlights

Upper Gastrointestinal Cancer

Guidelines

Evidence-based Guideline Recommendations on the use of Positron Emission Tomography Imaging in Oesophageal Cancer
March 2012(Vol. 24 | No. 2 | Pages 86-104)
R. Wong, C. Walker-Dilks, A. Raifu

Original Article

A Prognostic Model to Identify Patients with Advanced Pancreas Adenocarcinoma Who Could Benefit from Second-line Chemotherapy
March 2012(Vol. 24 | No. 2 | Pages 105-111)
Seung Tae Kim, Yoon Ji Choi, Kyong Hwa Park, Sang Cheul Oh, Jae Hong Seo, Sang Won Shin, Jun Suk Kim, Yeul Hong Kim

Palliative Radiotherapy

Original Articles

Update on the Systematic Review of Palliative Radiotherapy Trials for Bone Metastases
March 2012(Vol. 24 | No. 2 | Pages 112-124)
E. Chow, L. Zeng, N. Salvo, K. Dennis, M. Tsao, S. Lutz

Adjuvant Interferon Therapy for Patients at High Risk for Recurrent Melanoma: An Updated Systematic Review and Practice Guideline
16 January 2012
T. Petrella, S. Verma, K. Spithoff, I. Quirt, D. McCready, the Melanoma Disease Site Group
Abstract: After complete resection of melanoma, some patients remain at high risk for recurrence. The efficacy of adjuvant systemic therapy has been inconsistent in randomised trials and remains contr...
Intra-fraction Motion during Extreme Hypofractionated Radiotherapy of the Prostate using Pre- and Post-treatment Imaging
09 January 2012
H. Quon, D.A. Loblaw, P.C.F. Cheung, L. Holden, C. Tang, G. Pang, G. Morton, A. Mamedov, A. Deabreu
Abstract: Aims: To determine intra-fraction displacement of the prostate during extreme hypofractionated radiotherapy using pre- and post-treatment orthogonal images with three implanted gold seed fid...
Radionuclide Therapy in Neuroendocrine Tumours: A Systematic Review
06 January 2012
K.Y. Gulenchyn, X. Yao, S.L. Asa, S. Singh, C. Law
Abstract: The purpose of this systematic review was to investigate the effects of therapeutic radiopharmaceuticals in patients with different types of advanced neuroendocrine tumour (NETs). A literatu...
Long-term Outcomes and Prognostic Factors of Re-irradiation for Locally Recurrent Nasopharyngeal Carcinoma using Intensity-modulated Radiotherapy
03 January 2012
Fei Han, Chong Zhao, Shao-Min Huang, Li-Xia Lu, Ying Huang, Xiao-Wu Deng, Wei-Yuan Mai, Bin S. Teh, E. Brian Butler, Tai-Xiang Lu
Abstract: Aims: To analyse the outcomes and to evaluate the prognostic factors involved in the re-irradiation of locally recurrent nasopharyngeal carcinoma (NPC) using intensity-modulated radiotherapy...
Adaptive Radiotherapy Using Helical Tomotherapy for Head and Neck Cancer in Definitive and Postoperative Settings: Initial Results
26 December 2011
L. Capelle, M. Mackenzie, C. Field, M. Parliament, S. Ghosh, R. Scrimger
Abstract: Aims: To assess whether routine mid-treatment replanning in head and neck squamous cell carcinoma patients results in meaningful improvements in target or normal tissue dosimetry and to asse...

View More Articles in Press...

On the Cover

New Issue Alert

Free Trial Issue

See our companion journal, Clinical Radiology, also published by Elsevier.

About Clinical Oncology

Clinical Oncology, one of the official Journals of The Royal College of Radiologists (RCR), is essential reading for all those with an active interest in the treatment of cancer. Its multidisciplinary approach allows readers to keep up-to-date with developments in their own as well as related fields.

Each issue is carefully selected to provide a combination of high quality original research, informative editorials and state-of-the-art reviews. The Journal covers all aspects of the clinical management of cancer patients and its authors are drawn from leading international centres.

The Journal features papers on all types of malignant disease including pathology, diagnosis and therapy, including radiotherapy, and systemic treatment.

Publishing Information

Clinical Oncology is published by Elsevier for the Royal College of Radiologists.

Access this journal onSciVerse ScienceDirect

Journal Access

Full-text articles are available from 1989 to the present. Access to abstracts is complimentary. Access to full text is limited to Royal College of Radiologists members as well as personal subscribers.

Activate Online Access

About RCR

The Royal College of Radiologists (RCR) has approximately 7,500 members and Fellows worldwide representing the disciplines of clinical oncology and clinical radiology. All members and Fellows of the College are registered medical or dental practitioners. The role of the College is to advance the science and practice of radiology and oncology, further public education and promote study and research through setting professional standards of practice. The College is a charity registered with the Charity Commission (no. 211540). The College is responsible for setting the curriculum for its two specialties to ensure that high educational standards are met in the interests of safe and responsible practice, assessment of schemes for training in the specialties of clinical radiology and clinical oncology and defining and monitoring programmes of education and training for clinical radiologists and clinical oncologists at all stages of their careers. Other activities include encouraging members to keep up to date in advances in their specialty by organising programmes of continuing professional development (CPD), awarding prizes and scholarships, and funding travelling professorships and lectureships and acting as a major provider of education for clinical radiologists and clinical oncologists through lectures, conferences and seminars.